A combination therapy used as a first-line treatment for EGFR (Epidermal Growth Factor Receptor) mutation-positive lung cancer has been shown in a ...

For nearly 10 years, immunotherapy, since it was first introduced into Vietnam by MSD and approved by Vietnam’s Ministry of Health, has opened a new chapter in lung cancer treatment, offering ...

The IDeate-Lung01 trial showed a 48% confirmed response rate with Merck’s B7-H3 directed antibody-drug conjugate in previously treated extensive-stage small cell lung cancer, with durable benefit ...

Pancreatic, brain, lung, stomach and oesophageal cancers have seen hardly any change in survival rate over the past 50 years.

These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer ...

Lung cancer is a significant global health challenge, continuing to be the leading cause of cancer-related mortality worldwide. It contributes to ...